Clinical Research - Investigational Medicinal Product (IMP) Accountability

The purpose of this procedure is to ensure consistency in the performance of accountability tasks for IMP for clinical research, in compliance with NSW Health, SCHN, regulatory and Protocol requirements. Adherence to this procedure will ensure that: * Detailed records for IMP for clinical research are maintained providing details of all occasions of receipt, dispensing, transit/transfer, quarantine, return and/or destruction; and * IMP for clinical research is managed in accordance with the protocol-specific instructions of the Sponsor or Delegate and only used in accordance with, and for the purposes of the approved clinical research for which it has been provided.